Dimo Dietrich

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Dna Methylation

Top Venues

Clinical epigenetics

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz, Oliver Hahn, Thomas Büttner, Florian Roghmann, Christian Bolenz, Friedemann Zengerling, Constantin Schwab, Dora Nagy, Marieta Ioana Toma, Glen Kristiansen, Hendrik Heers, Philipp Ivanyi, Guenter Niegisch, Camilla Marisa Grunewald, Christopher Darr, Arian Farid, Katrin Schlack, Mahmoud Abbas, Can Aydogdu, Jozefina Casuscelli, Theresa Mokry, Michael Mayr, Dora Niedersüß-Beke, Steffen Rausch, Dimo Dietrich, Jonas Saal, Joerg Ellinger, Manuel Ritter, Abdullah Alajati, Christoph Kuppe, Joshua J Meeks, Francisco Emilio Vera-Badillo, José Alberto Nakauma-González, Joost Boormans, Kerstin Junker, Arndt Hartmann, Viktor Gruenwald, Michael Hudecek, Markus Eckstein
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (20) (2024)
Niklas Klümper, Lennert Wüst, Jonas Saal, Damian J Ralser, Romina Zarbl, Jonas Jarczyk, Johannes Breyer, Danijel Sikic, Bernd Wullich, Christian Bolenz, Florian Roghmann, Michael Hölzel, Manuel Ritter, Sebastian Strieth, Arndt Hartmann, Philipp Erben, Ralph M Wirtz, Jennifer Landsberg, Dimo Dietrich, Markus Eckstein
PD-L1 ( CD274 ) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma. Oncoimmunology 12 (1) (2023)
Konstantin Weber-Lassalle, Corinna Ernst, Alexander Reuss, Kathrin Möllenhoff, Klaus Baumann, Christian Jackisch, Jan Hauke, Dimo Dietrich, Julika Borde, Tjoung-Won Park-Simon, Lars C Hanker, Katharina Prieske, Sandra Schmidt, Nana Weber-Lassalle, Esther Pohl-Rescigno, Stefan Kommoss, Frederik Marmé, Florian Heitz, Julia Carolin Stingl, Rita K Schmutzler, Philipp Harter, Eric Hahnen
Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer. Journal of the National Cancer Institute 114 (4) (2022)
Dennis Niebel, Anne Fröhlich, Romina Zarbl, Simon Fietz, Luka de Vos, Timo J Vogt, Jörn Dietrich, Judith Sirokay, Pia Kuster, Gonzalo Saavedra, Susana Ramírez Valladolid, Friederike Hoffmann, Sebastian Strieth, Jennifer Landsberg, Dimo Dietrich
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy. Clinical epigenetics 14 (1) (2022)
Philip C Schouten, Lisa Richters, Daniel J Vis, Stefan Kommoss, Ewald van Dijk, Corinna Ernst, Roelof J C Kluin, Frederic Marmé, Esther H Lips, Sandra Schmidt, Esther Scheerman, Katharina Prieske, Carolien H M van Deurzen, Alexander Burges, Patricia C Ewing-Graham, Dimo Dietrich, Agnes Jager, Nikolaus de Gregorio, Jan Hauke, Andreas du Bois, Petra M Nederlof, Lodewyk F A Wessels, Eric Hahnen, Philipp Harter, Sabine C Linn, Rita K Schmutzler
Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Yilin Bao, Jennis Gabrielpillai, Jörn Dietrich, Romina Zarbl, Sebastian Strieth, Friederike Schröck, Dimo Dietrich
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors. Clinical epigenetics 13 (1) (2021)
Simon Fietz, Romina Zarbl, Dennis Niebel, Christian Posch, Peter Brossart, Gerrit H Gielen, Sebastian Strieth, Torsten Pietsch, Glen Kristiansen, Friedrich Bootz, Jennifer Landsberg, Dimo Dietrich
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab). Cancer immunology, immunotherapy : CII 70 (6) (2020)
Christopher Bockhorst, Jörn Dietrich, Timo J Vogt, Roland H Stauber, Sebastian Strieth, Friedrich Bootz, Dimo Dietrich, Luka de Vos
The DNA methylation landscape of PD-1 (PDCD1) and adjacent lncRNA AC131097.3 in head and neck squamous cell carcinoma. Epigenomics 13 (2) (2020)
Luka de Vos, Ingela Grünwald, Emma Grace Bawden, Jörn Dietrich, Kathrin Scheckenbach, Constanze Wiek, Romina Zarbl, Friedrich Bootz, Jennifer Landsberg, Dimo Dietrich
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas. Epigenetics 15 (11) (2020)
Friederike Hoffmann, Romina Zarbl, Dennis Niebel, Judith Sirokay, Anne Fröhlich, Christian Posch, Tobias A W Holderried, Peter Brossart, Gonzalo Saavedra, Pia Kuster, Sebastian Strieth, Gerrit H Gielen, Sandra S Ring, Jörn Dietrich, Torsten Pietsch, Lukas Flatz, Glen Kristiansen, Jennifer Landsberg, Dimo Dietrich
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma. Clinical epigenetics 12 (1) (2020)
Luka de Vos, Jörn Dietrich, Sebastian Strieth, Friedrich Bootz, Dimo Dietrich, Alina Franzen
PD-1, CTLA4, PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinoma. Immunotherapy 12 (12) (2020)
Madeleine Sassenberg, Johanna Droop, Wolfgang A Schulz, Dimo Dietrich, Sophia Marie Loick, Constanze Wiek, Kathrin Scheckenbach, Nadine Therese Gaisa, Michèle Janine Hoffmann
Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. BMC cancer 19 (1) (2019)
Tobias A W Holderried, Luka de Vos, Emma Grace Bawden, Timo J Vogt, Joern Dietrich, Romina Zarbl, Friedrich Bootz, Glen Kristiansen, Peter Brossart, Jennifer Landsberg, Dimo Dietrich
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma. Clinical epigenetics 11 (1) (2019)
Julia Bergheim, Alexander Semaan, Heidrun Gevensleben, Susanne Groening, Andreas Knoblich, Jörn Dietrich, Julia Weber, Jörg C Kalff, Friedrich Bootz, Glen Kristiansen, Dimo Dietrich
Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study. British journal of cancer 118 (9) (2018)
Verena Sailer, Arthur Charpentier, Joern Dietrich, Timo J Vogt, Alina Franzen, Friedrich Bootz, Dimo Dietrich, Andreas Schroeck
Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas. PloS one 13 (2) (2018)
Verena Sailer, Heidrun Gevensleben, Joern Dietrich, Diane Goltz, Glen Kristiansen, Friedrich Bootz, Dimo Dietrich
Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma. PloS one 12 (6) (2017)
Luka de Vos, Heidrun Gevensleben, Andreas Schröck, Alina Franzen, Glen Kristiansen, Friedrich Bootz, Dimo Dietrich
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients. Clinical epigenetics 9 (2017)